Thomas Ciulla Clearside Biomedical, Inc. (CLSD) insider trading activity

Thomas Ciulla is Chief Medical Officer of Clearside Biomedical, Inc.. Currently has a direct ownership of 291,890 shares of CLSD, which is worth approximately $253,944. The most recent transaction as insider was on Jan 20, 2023, when has been sold 13,700 shares (Common Stock) at a price of $1.47 per share, resulting in proceeds of $20,139. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 292K

0% 3M change

0% 12M change

Total Value Held $253,944

Thomas Ciulla Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 20 2023	SELL Open market or private sale	$20,139 $1.47 p/Share	13,700 Reduced 4.48%	291,890 Common Stock
Jan 10 2023	SELL Open market or private sale	$3,515 $1.62 p/Share	2,170 Reduced 0.71%	305,590 Common Stock
Dec 31 2022	BUY Grant, award, or other acquisition	$4,750 $0.95 p/Share	5,000 Added 1.6%	307,760 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$6,250 $1.25 p/Share	5,000 Added 1.62%	302,760 Common Stock
Jan 19 2022	SELL Open market or private sale	$19,277 $2.13 p/Share	9,050 Reduced 2.97%	295,260 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	43,750 Added 12.75%	299,310 Common Stock
Sep 21 2021	SELL Open market or private sale	$16,384 $6.4 p/Share	2,560 Reduced 0.99%	255,560 Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	103,125 Added 28.95%	253,122 Common Stock

Also insider at

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Chief Medical Officer

Thomas Ciulla

Chief Medical Officer

Alpharetta, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLSD shares.

Notify only if

Value

Insider Trading

Get notified when an Clearside Biomedical, Inc. insider buys or sells CLSD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Clearside Biomedical, Inc.

Track Activities on CLSD

Account